5 years ago

MIP Diagnostics Secures £5.1M Funding to Accelerate Global Expansion

  • MIP Diagnostics, a UK-based nanotechnology business, has secured £5.1 million in funding led by Downing Ventures

  • The company will use the funds to expand globally, build its in-house R&D team, invest in commercial resources, and scale up its manufacturing capacity

  • MIP Diagnostics develops and manufactures synthetic affinity reagents using Molecularly Imprinted Polymers (MIPs) and nanoMIPs, which have applications in point-of-care diagnostics, IVDs, healthcare, and bioprocessing.

      • ProblemHealthcare

      "The problem is that traditional antibodies for diagnostic tests have limitations, such as the need for cold storage and sensitivity to chemicals."

      Solution

      "MIP Diagnostics offers a proprietary process for synthetic polymer alternatives to antibodies, allowing for a range of applications including point-of-care diagnostics and more"

      Covered on